<?xml version="1.0" encoding="UTF-8"?>
<p>To compare the performance of the SD Bioline Dengue Duo test with conventional ELISA testing, 74 of the 92 acute phase serum samples (
 <bold>
  <xref ref-type="fig" rid="pone.0230337.g003">Fig 3A</xref>
 </bold>) were analyzed with the Platelia NS1 Antigen ELISA (
 <bold>
  <xref ref-type="fig" rid="pone.0230337.g003">Fig 3B</xref>
 </bold>), the Panbio μ-capture ELISA (
 <bold>
  <xref ref-type="fig" rid="pone.0230337.g003">Fig 3C</xref>
 </bold>), and the Panbio IgG ELISA (
 <bold>
  <xref ref-type="fig" rid="pone.0230337.g003">Fig 3D</xref>
 </bold>). While a good concordance was observed between the SD Bioline Dengue Duo NS1 test and the Platelia NS1 Antigen ELISA results (
 <bold>
  <xref ref-type="fig" rid="pone.0230337.g003">Fig 3B</xref>
 </bold> and 
 <bold>
  <xref ref-type="fig" rid="pone.0230337.g003">3E</xref>
 </bold>; Cohen’s kappa 0.78), only a low percentage of the samples classified as IgM/IgG positive by the Panbio μ-capture and IgG ELISA test, respectively, also generated a positive result in the SD Bioline Dengue Duo IgM/IgG test (
 <bold>
  <xref ref-type="fig" rid="pone.0230337.g003">Fig 3C and 3D</xref>
 </bold>). Similarly, only a moderate agreement (Cohen’s kappa 0.42) was found between the SD Bioline Dengue Duo IgG test and the DENV IgG IIFT (
 <xref ref-type="fig" rid="pone.0230337.g003">Fig 3E</xref>) while the DENV IgG IIFT and the Panbio IgG ELISA were in good concordance (
 <bold>
  <xref ref-type="supplementary-material" rid="pone.0230337.s006">S5 Fig</xref>
 </bold>, Cohen’s kappa 0.75).
</p>
